These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2515579)

  • 21. Parasitological and Biochemical Efficacy of the Active Ingredients of
    Abu Almaaty AH; Rashed HAE; Soliman MFM; Fayad E; Althobaiti F; El-Shenawy NS
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the efficacy of the new antischistosomal drug 10-[2-(diethylamino)ethyl]-9-acridanone-(thiazolidin-2-ylidene) hydrazone against an Egyptian strain of S. mansoni in mice.
    Metwally A; Abdel Hadi A; Mikhail EG; Aboú Shadi O; Sabry H; el-Nahal H
    Arzneimittelforschung; 1997 Aug; 47(8):975-9. PubMed ID: 9296287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone.
    Probst A; Häberli C; Siegel D; Huang J; Vigneron S; Ta AP; Skinner DE; El-Sakkary N; Momper JD; Gangoiti J; Dong Y; Vennerstrom JL; Charman SA; Caffrey CR; Keiser J
    J Antimicrob Chemother; 2020 Oct; 75(10):2925-2932. PubMed ID: 32617557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of garlic on Schistosoma mansoni harbored in albino mice: molecular characterization of the host and parasite.
    Riad NH; Taha HA; Mahmoud YI
    Gene; 2013 Apr; 518(2):287-91. PubMed ID: 23414971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal.
    Keiser J; Panic G; Vargas M; Wang C; Dong Y; Gautam N; Vennerstrom JL
    J Antimicrob Chemother; 2015; 70(6):1788-97. PubMed ID: 25691324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain.
    El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
    Exp Parasitol; 2013 Oct; 135(2):240-5. PubMed ID: 23876575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology.
    Xiao SH; Guo J; Chollet J; Wu JT; Tanner M; Utzinger J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):148-53. PubMed ID: 15597709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
    Barakat R; Elmorshedy H; Fenwick A
    Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone derivative, against Schistosoma haematobium.
    Guirguis FR
    Arzneimittelforschung; 2003; 53(1):57-61. PubMed ID: 12608016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice.
    El-Ansary AK; Ahmed SA; Aly SA
    Indian J Exp Biol; 2007 Sep; 45(9):791-801. PubMed ID: 17907745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic evaluation of oltipraz in human S. mansoni infection].
    de Carvalho SA; Amato Neto V; Zeitune JM; Shikanai-Yasuda MA; Takiguti CK
    Rev Inst Med Trop Sao Paulo; 1986; 28(4):271-7. PubMed ID: 3105039
    [No Abstract]   [Full Text] [Related]  

  • 32. Schistosoma mansoni: biochemical characteristics of the antischistosomal effects of Ro 15-5458.
    Eshete F; Bennett JL
    Exp Parasitol; 1990 Jul; 71(1):69-80. PubMed ID: 2113009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of PEG-interferon-alpha-2A on Schistosoma mansoni infection in mice.
    Draz HM; Mahmoud SS; Ashour E; Shaker YM; Wu CH; Wu GY
    J Parasitol; 2010 Aug; 96(4):703-8. PubMed ID: 20486736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo.
    Manneck T; Braissant O; Ellis W; Keiser J
    Exp Parasitol; 2011 Jan; 127(1):260-9. PubMed ID: 20732321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antischistosomal activity of artemether in experimental Schistosomiasis mansoni].
    Lescano SZ; Chieffi PP; Canhassi RR; Boulos M; Amato Neto V
    Rev Saude Publica; 2004 Feb; 38(1):71-5. PubMed ID: 14963544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni.
    Cowan N; Yaremenko IA; Krylov IB; Terent'ev AO; Keiser J
    Bioorg Med Chem; 2015 Aug; 23(16):5175-81. PubMed ID: 25744189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oltipraz treatment in experimental schistosomiasis mansoni. II. Effect of high dose oral therapy on worm load and process of copulation in infected mice.
    Aboul-Atta AM; Hassan ZA; el-Ahl SS
    J Egypt Soc Parasitol; 1989 Dec; 19(2):427-36. PubMed ID: 2504822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.